BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23585849)

  • 1. Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition.
    Pérez-Lozano ML; Sandoval P; Rynne-Vidal A; Aguilera A; Jiménez-Heffernan JA; Albar-Vizcaíno P; Majano PL; Sánchez-Tomero JA; Selgas R; López-Cabrera M
    PLoS One; 2013; 8(4):e60776. PubMed ID: 23585849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis.
    Man XY; Yang XH; Cai SQ; Yao YG; Zheng M
    Mol Med; 2006; 12(7-8):127-36. PubMed ID: 17088944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.
    Loureiro J; Sandoval P; del Peso G; Gónzalez-Mateo G; Fernández-Millara V; Santamaria B; Bajo MA; Sánchez-Tomero JA; Guerra-Azcona G; Selgas R; López-Cabrera M; Aguilera AI
    PLoS One; 2013; 8(4):e61165. PubMed ID: 23637793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of bicarbonate/low-GDP peritoneal dialysis fluid (BicaVera) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells.
    Fernández-Perpén A; Pérez-Lozano ML; Bajo MA; Albar-Vizcaino P; Sandoval Correa P; del Peso G; Castro MJ; Aguilera A; Ossorio M; Peter ME; Passlick-Deetjen J; Aroeira LS; Selgas R; López-Cabrera M; Sánchez-Tomero JA
    Perit Dial Int; 2012; 32(3):292-304. PubMed ID: 22215656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
    Teran M; Nugent MA
    J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation.
    Catalano A; Caprari P; Rodilossi S; Betta P; Castellucci M; Casazza A; Tamagnone L; Procopio A
    FASEB J; 2004 Feb; 18(2):358-60. PubMed ID: 14656993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
    Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
    Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-β1/Smad3 signaling pathway.
    Jiang N; Zhang Z; Shao X; Jing R; Wang C; Fang W; Mou S; Ni Z
    J Cell Physiol; 2020 Jan; 235(1):364-379. PubMed ID: 31236971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.
    Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
    J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses.
    Namvar S; Woolf AS; Zeef LA; Wilm T; Wilm B; Herrick SE
    J Pathol; 2018 Aug; 245(4):491-501. PubMed ID: 29774544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
    Straume O; Akslen LA
    Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients.
    Bernatz S; Monden D; Gessler F; Radic T; Hattingen E; Senft C; Seifert V; Ronellenfitsch MW; Plate KH; Harter PN; Baumgarten P
    J Mol Histol; 2021 Apr; 52(2):233-243. PubMed ID: 33528717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
    Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A
    Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity.
    Ottino P; Finley J; Rojo E; Ottlecz A; Lambrou GN; Bazan HE; Bazan NG
    Mol Vis; 2004 May; 10():341-50. PubMed ID: 15162095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
    Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V
    FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients.
    Ruiz-Carpio V; Sandoval P; Aguilera A; Albar-Vizcaíno P; Perez-Lozano ML; González-Mateo GT; Acuña-Ruiz A; García-Cantalejo J; Botías P; Bajo MA; Selgas R; Sánchez-Tomero JA; Passlick-Deetjen J; Piecha D; Büchel J; Steppan S; López-Cabrera M
    Sci Rep; 2017 Mar; 7():44941. PubMed ID: 28327551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium.
    Punyadeera C; Thijssen VL; Tchaikovski S; Kamps R; Delvoux B; Dunselman GA; de Goeij AF; Griffioen AW; Groothuis PG
    Mol Hum Reprod; 2006 Jun; 12(6):367-75. PubMed ID: 16648151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.